PGNX - Progenics Pharmaceuticals Inc.

$4.33 0.15 | 3.59%
Today's Range: 4.07 - 4.33
PGNX Avg. Daily Volume: 175,718
12/21/09 - 4:00 PM ET
TRADE NOW
Company Income Statement
Dec 2008 Dec 2007 Dec 2006 Dec 2005
Sales 67.67M 75.65M 69.91M 9.49M
Cost of Sales -960.00K 445.00K -9.00K -2.15M
Gross Operating Profit 68.62M 75.20M 69.92M 11.63M
Selling, General, and Administrative Expenses 28.83M 27.90M 22.26M 13.56M
Research & Development 85.12M 96.18M 75.31M 63.84M
Operating Income before D & A (EBITDA) -45.34M -48.88M -27.65M -65.77M
Depreciation & Amortization 5.57M 2.58M 1.54M 3.90M
Interest Income 6.24M 7.77M 7.70M 2.30M
Other Income - Net 0.00 0.00 -121.00K -1.86M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -44.67M -43.69M -21.62M -69.23M
Interest Expense 0.00 0.00 0.00 0.00
Pre-Tax Income -44.67M -43.69M -21.62M -69.23M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -44.67M -43.69M -21.62M -69.23M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -44.67M -43.69M -21.62M -69.23M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -44.67M -43.69M -21.62M -69.23M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 -44.67M -43.69M -21.62M -69.23M
Preferred Dividends
Net Income Available To Common -44.67M -43.69M -21.62M -69.23M
Basic EPS from Continuing Ops. -1.51 -1.60 -0.84 -3.33
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.51 -1.60 -0.84 -3.33
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -1.51 -1.60 -0.84 -3.33
Basic Normalized Net Income/Share -1.51 -1.60 -0.84 -3.33
EPS fr Continuing Ops. -1.51 -1.60 -0.84 -3.33
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.51 -1.60 -0.84 -3.33
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -1.51 -1.60 -0.84 -3.33
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 -1.51 -1.60 -0.84 -3.33
Dividends Paid per Share 0.00 0.00 0.00 0.00
Latest PGNX Headlines
More Financial News for PGNX
Partner Headlines

Brokerage Partners

TheStreet Premium Services

All Services